Our IP specialists work at all stage of the IP life cycle and provide strategic advice about patent, trade mark and registered designs, as well as any IP-related disputes and legal and commercial requirements.
Scott is a member of our life sciences practice group, working primarily in the biopharma sector. Scott has experience prosecuting patent applications for both local and international clients, and has worked on offensive and defensive oppositions before the EPO.
Areas of Expertise
- molecular and cell biology;
- enzyme technology;
- diagnostics and prognostics
Scott’s clients include drug discovery/development companies in Europe and the US which include companies working with stem cell-enabling technologies, immune-oncology therapies, and diagnostic and prognostic technologies. Scott also works with Korea-based biopharma companies that focus on therapeutic proteins and industrial fermentation.
Scott has an MSci in Pharmacology from the University of Glasgow, which included a year spent working in industry at Pfizer’s Sandwich laboratories. He also has a PhD in Neuroscience from Imperial College London. His doctoral research focused on neuronal mechanisms of anaesthesia and neuroprotection.
Scott joined Mewburn Ellis in 2015, qualifying as a Chartered Patent Attorney and a European Patent Attorney in 2018.